BiotechTube
Home/SylamoreBio/Walter Acosta
WA

Walter Acosta

Chief Science Officer

SylamoreBio

Therapeutic Areas

NeurologyRare DiseasesMusculoskeletal

SylamoreBio Pipeline

DrugIndicationPhase
Lectin-Fusion for LSDs (e.g., MPS I, Pompe)Lysosomal Storage Disorders with CNS involvementPre-clinical
Lectin-Fusion for Bone/Muscle DisordersMusculoskeletal pathologies, abnormal bone growthPre-clinical

Leadership Team at SylamoreBio

RL
Regina Leung
CEO
CC
Carole Cramer
President
View full SylamoreBio profile